Amyotrophic lateral sclerosis (ALS)
Review over Amyotrophic Lateral Sclerosis (ALS) and the First FDA-Approved Drug for Treatment of ALS: Introduction Amyotrophic lateral sclerosis (ALS) is a progressive nervous system disease that affects nerve cells which control voluntary muscle movement. Patient’s sensory functions or mental faculties doesn’t changed through ALS. ALS is considered as a progressive disease. There is […]
Molnupiravir
Molnupiravir may be effective against the omicron sub-variant BA.5 According to a study published in the New England Journal of Medicine on Thursday, a team led by a professor of virology at the University of Tokyo, found that small-molecule antiviral drug molnupiravir curbed virus activity in cultured monkey cells infected with the highly contagious […]
Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis (ALS) Global Day Annually the International ALS/MND Associations celebrates 21 June as the global day of recognition of ALS/MND, a disease that affects people in every country of the world. ALS/MND is a global problem. It doesn’t discriminate on the basis of ethnicity or region, there are patients all over the world. For every […]
WHO Backs Molnupiravir for High-Risk Covid-19 Patients
The ninth update of WHO’s guideline on COVID-19 therapeutics includes a conditional recommendation on molnupiravir, a new antiviral medicine. This is the first oral antiviral medicine which is included in the treatment guidelines for COVID-19, as this is a new medicine, there is little safety information; WHO recommends active monitoring for drug safety, along […]
Arthritis
World AUTO immune & AUTO inflammatory Arthritis Day This event historically unites thousands of people in 60+ countries worldwide to drive global awareness and education about the Autoimmune and Auto-inflammatory diseases that include inflammatory-driven arthritis. There is no other globally program focused on Autoimmune Arthritis and associated diseases that is as big and has […]
Monkeypox
The current monkeypox situation is consistently evolving and subject to change. The aim of this Disease Outbreak News is to raise public awareness, inform readiness and response efforts, and provide technical guidance for immediate needed actions. Outbreak at glance Since 13 May 2022, cases of monkeypox have been reported from 12 Member States that are […]
Breaking news; U.S FDA advisory panel narrowly endorses Molnupiravir
Breaking news; U.S FDA advisory panel narrowly endorses Molnupiravir U.S FDA advisory panel narrowly endorses Molnupiravir, for Mild to Moderate COVID-19 in High Risk patients, despite reduced efficacy and safety questions . A Food and Drug Administration advisory panel on Tuesday narrowly endorsed the use of Merck and Ridgeback’s at-home Covid treatment pill, despite questions about […]